Of 68 patients with unclippable aneurysms treated by proximal artery occlusion with detachable balloons, permanent occlusion was achieved in 65; of these patients, 37 had carotid artery aneurysms below the origin of the ophthalmic artery, 21 had aneurysms arising from the supraclinoid portion of the carotid artery, six had basilar trunk aneurysms, and one bad a distal vertebral aneurysm. Examination for treatment selection included assessment of the circle of Willis by compression angiography and xenon blood flow studies, with the ultimate evaluation being test occlusion under systemic heparinization with the balloon temporarily placed in the desired position. Of 67 patients who underwent a formal occlusion test, eight with carotid artery aneurysms did not initially tolerate the occlusion test, and ischemic signs disappeared instantaneously with deflation and removal of the balloon. During test occlusion, two additional patients had ischemic events that proved to be embolic; these reversed immediately upon balloon deflation.
T HE accepted method of treatment for cerebral aneurysms is surgical clipping of the aneurysm neck. However, because of location, size, or wall thickness, it is not always possible to surgically clip these aneurysms. For unclippable carotid artery aneurysms, occlusion of the carotid artery is still an accepted treatment, ~l with the occlusion being performed by surgical ligation, Selverstone clamp, 8,11,~3 Drake tourniquet, 4 or detachable balloon. ~'2a2 The use of parent vessel occlusion has been expanded to include one or both vertebral arteries as well as most of the major intracranial arteries giving rise to giant aneurysms. 4, 5 Some innovative techniques have also been used for obliteration of aneurysms without clipping or occluding the parent artery; these methods include insertion of fine metallic wires into the aneurysm and detachment of a balloon within the aneurysm sac. 2'1~ Detachable balloon occlusion of carotid or vertebral arteries as a treatment for unclippable cerebral aneurysms 1'2 is different from the Selverstone clamp technique. In detachable balloon occlusion, the patient is awake and the balloon is placed into the carotid or vertebral artery using the Seldinger intra-arterial catheter technique. The Selverstone clamp is placed sur-gically, usually under general anesthesia. The detachable balloon is used to produce acute occlusion, whereas the Selverstone clamp can be closed in stages. It is important to know that, following its detachment, the balloon cannot easily be removed to reverse occlusion whereas the Selverstone clamp can be opened quickly at any time within the first 2 or 3 days. We have used the detachable balloon as the treatment approach for proximal occlusion of the parent artery for unclippable aneurysms in 68 patients. This report describes our current protocol and the results obtained in this series of patients.
Clinical Material and Methods

Clinical Material
Since 1978, at University Hospital in London, Ontario, 68 patients with unclippable aneurysms have been treated by proximal artery occlusion with the Debrun latex detachable balloon. Permanent occlusion was effected in 65 of these patients. This series does not include cases of non-detachable balloon used as an adjunct to surgical clipping or balloons placed within the lumen of an aneurysm without occluding the artery. Of the 65 who were successfully treated, 37 had aneurysms of the cavernous or petrous carotid artery (below the origin of the ophthalmic artery), including three cavernous aneurysms that presented as spontaneous carotid-cavernous fistulas; 21 had aneurysms in the supraclinoid portion of the carotid artery, either at or above the ophthalmic artery origin; six had unclippable aneurysms of the proximal trunk of the basilar artery and required balloon occlusion of one or both vertebral arteries; and one had a distal vertebral aneurysm treated by balloon occlusion of the vertebral artery. The presentation of the cases in this series is listed in Table 1 along with the clinical findings as they relate to aneurysm location.
Balloons Detached Within Aneurysm Sac
Early in our experience with detachable balloons, we treated seven cases by placing a detachable balloon inside the aneurysm sac in order to preserve the parent artery. These were all aneurysms of the cavernous carotid artery. Three of these aneurysms were primary and four were secondary (one was secondary to transsphenoidal surgery and three were symptomatic residual pseudoaneurysms resulting from successful detachable balloon treatment of traumatic carotid-cavernous fistulas). Various complications were encountered in this small group of cases, some of which have been reported previously. 2 These problems included: balloon deflation causing aneurysm refilling and recurrence of symptoms; cerebral abscess in a case with multiple balloons placed inside a giant aneurysm; repeat epistaxis; transient ischemic attacks (TIA's) caused by the balloon entering the aneurysm or bulging into the carotid artery; and severe stenosis of the carotid artery due to bulging of the balloon which progressed to complete occlusion. Balloon occlusion of the carotid artery was then carried out in four of these seven cases without further event, and these are included in the series of 68 patients. Because of the many problems encountered in this small group of initially treated patients, the use of detachable balloons to treat unclippable aneurysms in our unit has been restricted to proximal balloon occlusion of the carotid or vertebral artery.
Technical Protocol
The treatment approach for cranial artery occlusion by detachable balloon has been developed over a number of years. Our current protocol is outlined in Table  2 . Patients referred to our institution are placed under the primary care of a neurosurgeon, and he determines if an aneurysm is unclippable. This is often established after surgical exploration for supraclinoid carotid or vertebrobasilar aneurysms. The decision to use detachable balloons to occlude the parent vessel is made jointly by the neurosurgeon and neuroradiologist. The decision whether to perform an extracranial to intracranial artery (EC-IC) anastomosis 4'6'7'11 prior to carotid artery occlusion is made by the neurosurgeon based on the following: a compression angiogram demonstrating the The superficial temporal artery bypass procedure contributes significantly to the middle cerebral artery circulation, but without the retrograde proximal filling noted in c.
circle of Willis; the clinical assessment; and (in most instances) a xenon cerebral blood flow study 6 during carotid artery compression. A similar decision is made for patients undergoing occlusion of the vertebral artery for posterior fossa aneurysm based on assessment of the circle of Willis by vertebral angiography. The carotid arteries are compressed to demonstrate the patency of their respective posterior communicating arteries.
The actual balloon-catheter procedure is carried out with the patient awake and under local anesthesia using femoral artery catheterization. Patients are premedicated with aspirin (650 mg twice a day) for at least 1 day. A No. 6 French introducer catheter is placed through the femoral artery sheath and constantly infused with heparinized saline (3000 units heparin/500 cc saline). In addition, a bolus of 2000 units of heparin 3 is administered prior to insertion of the balloon. A No. 16 Debrun latex balloon catheter attached to a Teflon coaxial catheter system is placed through the introducer catheter and located in the carotid or vertebral artery at a level below the aneurysm under fluoroscopic control. The balloon is inflated with contrast material to effect arterial occlusion, and the patient is then carefully monitored for at least 15 minutes to determine hemodynamic tolerance to the occlusion. If occlusion is tolerated for at least 15 minutes, the balloon is detached and a second balloon is placed below the first one as a "fail-safe" mechanism. This prevents the first balloon from becoming a distal embolus in the event that it deflates prematurely? If the test occlusion is not tolerated ( Fig. 1 ) the balloon is deflated and removed; this process can be carried out before the balloon is detached and produces immediate reversal of a neurological deficit. Following completion of the procedure, protamine sulfate is administered to reverse the effect of the heparin and the femoral catheter is removed.
In the immediate postocclusion period, patients are kept well hydrated and are closely monitored. Antiplatelet agents (aspirin and/or Persantine (dipyridamole)) are given; many of our recent patients have received low-dose heparin therapy as well, about 4 hours after removal of the femoral catheter. This regimen is continued for a couple of days to prevent formation of an embolism from the thrombosing aneurysm or from the carotid artery segment above the balloon. If an ischemic complication occurs, treatment also includes therapeutic hypertension and volume expansion.
In the series reported here, the aneurysms of the carotid artery located below the level of the ophthalmic artery and the one vertebral artery aneurysm were proven, on an angiogram obtained at the end of the procedure, to be completely obliterated and effectively isolated from the circulation. In nearly every patient with a carotid artery aneurysm located at or above the ophthalmic artery origin or with a basilar trunk aneurysm, the immediate post-detachment control angiogram showed contrast material filling the aneurysmal sac from ophthalmic artery or posterior communicating artery collateral routes, while the patients were still systemically heparinized. In cases such as these, a late follow-up control angiogram with injection of all possible collateral sources is necessary to evaluate the degree of aneurysm thrombosis produced by the change in flow pattern and turbulence in the region of the aneurysm. Control angiograms obtained a few weeks or months later are more likely to show maximal thrombosis. Therefore, we usually perform control angiography about 1 week following occlusion (Fig. 2) and, if the aneurysm is still seen, repeat it some months later.
Operative Results
Balloon Occlusion Test Not Tolerated
Eight of the 67 patients who underwent the occlusion test (60 for carotid artery occlusion and seven for vertebral artery occlusion) did not initially tolerate the occlusion. All eight had unclippable aneurysms of the intracranial carotid artery. Four patients failed the balloon occlusion test following an EC-IC bypass procedure. Two of these subsequently tolerated the test without further surgical anastomosis: one had failed to tolerate occlusions attempted 1 day, 1 week, and 1 month following bypass surgery, but then tolerated the balloon occlusion test 8 months later (Fig. 1) . The other two were not treated further with balloon occlusion.
Four patients did not have EC-IC bypass surgery prior to initial balloon occlusion testing. One presented with subarachnoid hemorrhage and had vasospasm. It was decided to test balloon occlusion a second time 10 days later, at which time she tolerated the occlusion without the necessity for a bypass procedure. Another failed to tolerate occlusion the day following exploration, but tolerated occlusion 5 days later. In one case it was decided to perform bypass surgery and to occlude the artery with a Selverstone clamp. In another case a bypass procedure was performed and the patient tolerated the balloon occlusion test, although problems developed later (Case 1, Table 3 ).
In the eight patients who did not tolerate the test occlusion, signs of cerebral ischemia began between 30 seconds and 7 minutes after occlusion. In each case, the signs and symptoms reversed almost instantaneously following deflation and removal of the balloon from the carotid artery. The balloon occlusion test itself was not responsible for any serious or permanent complications.
During the test occlusion procedure, two carotid aspirin, heparin stroke in 2nd wk aspirin complete recovery (3 mos) * TIA = transient ischemic attack; CPR = cardiopulmonary resuscitation; RIND = reversible ischemic neurological deficit; SAH = subarachnoid hemorrhage.
artery aneurysms, one at the bifurcation and one paraophthalmic, were associated with a TIA that was proven to be caused by emboli. In both instances the procedure was stopped and the patient completely recovered. These patients then tolerated balloon occlusion 3 or 4 days later without a bypass procedure; one of these (Case 9, Table 3 ) suffered a stroke in the 2nd postembolization week. Since there was compelling evidence that the TIA's were embolic in origin (one patient had the TIA when the balloon was not inflated, and the other showed a rolandic branch occlusion on angiography minutes later), we do not consider these patients as having failed the occlusion test.
Cerebral Complications of Artery Occlusion
Among the 65 patients in whom carotid or vertebral artery occlusion was effected by detachable balloon, there were nine cerebral complications (Table 3) . Eight of these patients had carotid artery occlusion (of 58 carotid aneurysm cases treated by occlusion) and one had occlusion of the vertebrobasilar circulation (of seven such cases treated).
The complications in five of these patients were TIA's occurring within the first 24 hours after occlusion. Two patients (Cases 1 and 8) had single episodes of arm or hand numbness occurring within 24 hours following occlusion, one (Case 2) had an episode of mild drift of the arm at 24 hours, and one (Case 6) had a drift involving both arm and leg which was observed 4 to 8 hours following the occlusion. All four mild episodes were treated with volume expansion and aspirin, and three cases were additionally treated with heparin, with no recurrence in any of them. The fifth patient with TIA's (Case 3) developed a stroke 5 to 20 hours after occlusion that resulted in hemiparesis and aphasia. She was treated with volume expansion, aspirin, and hepatin and recovered completely over the next week.
Another patient (Case 7) began to have TIA's the day after occlusion and was treated with volume expansion and heparin. She had failed the balloon occlusion test elsewhere, but had otherwise done well following bypass surgery. On the 4th day she developed a stroke, had a cardiac arrest, and was resuscitated. Computerized tomography revealed subarachnoid blood and deep ischemic areas, and the bypass was then seen to fill only poorly on angiography. It was thought that the aneurysm had ruptured, although it was later shown to be obliterated by thrombosis. She improved over the next week but was left with a residual leg weakness. One patient (Case 4), who presented with seizures from a giant carotid bifurcation aneurysm, suffered a seizure and respiratory arrest 4 days following balloon occlusion but was successfuly resuscitated without recurrent problems. Another patient (Case 5) had TIA's involving the leg which began 1 month after balloon occlusion (the ipsilateral anterior cerebral artery had been perfused mainly by the contralateral internal carotid artery even prior to balloon occlusion). She was treated with anticoagulant agents but suffered a subdural hematoma 6 months later, associated with an exceptionally high prothrombin time. She remained in poor condition despite removal of the hematoma. The last patient (Case 9) had had an embolic episode during the first occlusion attempt, without residua. She tolerated the occlusion 5 days later, but had a stroke in the 2nd week following occlusion, with complete recovery.
Results of Balloon Occlusion
The overall results of the aneurysm cases treated by proximal carotid or vertebral artery balloon occlusion are summarized in Table 4 . All of the 37 patients with unclippable aneurysms of the carotid artery located below the origin of the ophthalmic artery, mainly cavernous ( Fig. 1) , had complete aneurysm obliteration effected by balloon occlusion proximal to the aneurysm, Eleven of these 37 patients had an EC-IC bypass procedure prior to occlusion (Fig. 1) . Three (Cases 1, 3, and 5, Table 3 ) had ischemic complications as mentioned above. Two patients had transient worsening of cranial nerve palsy attributed to pressure from slight expansion of the thrombosing aneurysm.
Ten of the 21 patients with unclippable aneurysms of the carotid artery situated between the ophthalmic origin and the bifurcation showed complete aneurysm thrombosis on late follow-up angiograms. This was produced only by the change in flow pattern and subsequent change in pressure and turbulence produced by the proximal balloon occlusion. The other 11 cases either required an additional intracranial trapping procedure to achieve complete aneurysm obliteration or were treated too recently for complete evaluation. Of the 21 cases treated in this group, 14 had an EC-IC bypass procedure prior to occlusion which was usually performed when the neck of the aneurysm was explored. Four patients (Cases 2, 7, 8, and 9, Table 3 ) had ischemic complications following occlusion as mentioned above, and three of these had transient worsening of a cranial nerve palsy attributable to pressure from the thrombosed aneurysm. Another patient (Case 4) had a seizure leading to respiratory arrest on the 4th day after balloon occlusion but had no residua after resuscitation.
Six patients were treated by vertebral artery occlusion for a basilar trunk aneurysm. Three of these aneurysms were completely obliterated by proximal occlusion (Fig.  2) . One patient (Case 6, Table 3 ) had a reversible ischemic episode as mentioned above. One patient with a dissecting aneurysm of the intracranial portion of the right vertebral artery was treated with balloon occlusion and no complications ensued.
Therefore, in 50 (76.9%) of the 65 patients undergoing proximal artery occlusion for intracranial aneurysm, the aneurysms were completely obliterated by the proximal occlusion with a 12.3% incidence (eight cases) of delayed ischemia and a 1.5% incidence (one case) of residual deficit (leg weakness).
Discussion
For aneurysms of the cavernous segment of the carotid artery and for giant unclippable intracranial aneurysms, we consider occlusion of the parent artery to be the treatment of choice. 4"s,1~ The most commonly used technique has been a Selverstone clamp placed on the internal carotid artery. This clamp is used to close the artery progressively, and the procedure can be reversed by unscrewing the clamp. The use of detachable balloons to occlude the parent artery 1' 2 may cause concern because the occlusion is abrupt and permanent. However, these concerns are not borne out by the results in our series, which demonstrated 0% mortality and 1.5% permanent morbidity attributable to this technique of occluding the parent artery by a detachable balloon.
The outcome was excellent in the four cases of ischemia that occurred within 24 hours of balloon occlusion. The treatment (volume expansion, antiplatelet agents, and heparin therapy) was effective, and there was no recurrence. The inability to reverse occlusion did not have a detrimental effect on the outcome. Had the Selverstone clamp been used, the therapeutic options would not have been different for the patient who had TIA's and then a stroke on the 4th day, for the patient who had a seizure and respiratory arrest 4 days following occlusion, for the patient with TIA's 1 month after occlusion, or for the patient who had a stroke in the 2nd week. The reversal of occlusion by the Selverstone clamp some days later (it has been opened up to 3 days later in our neurosurgery unit) risks pushing large emboli up the carotid artery to the brain. Therefore, no risks attributable to the use of balloons that would not also have been present with the Selverstone clamp have come to our attention in these patients.
The 15-minute occlusion test under systemic heparinization prior to occlusion appears to be important in assessing hemodynamic tolerance. The eight patients exhibiting hemispheric signs during the carotid occlusion test all showed reversal of the signs on balloon deflation. This shows evidence of the safety of the occlusion test when it is accompanied by systemic heparinization. The efficacy of this test supports the idea that delayed ischemic complications of occlusion are due to peripheral embolization (from the aneurysm or distal arterial stump),1'2"4 to hypotensive episodes, or to both. Such events are best managed by volume expansion and anticoagulation, and possibly by hypertensive medication during the acute stages. Since ischemic episodes occurring hours after complete occlusion are likely due to small emboli from the distal surface of propagating clot, the risk of reversing occlusion at that time is alarming because restoration of arterial blood flow could well be associated with intracranial embolization of much larger amounts of clot. Overall, the results in these cases of balloon occlusion, in combination with the balloon occlusion test, indicate that it is a reasonable and simple alternative to artery ligation or clamp occlusion methods.
Our method of balloon occlusion is slightly different from the method described by Berenstein, et al. ~ Our technique, using the same balloon for the occlusion test as for detachment, is simpler than Berenstein's technique of using a separate balloon catheter system for the test. Since most patients will tolerate occlusion if there is sufficient natural collateral flow or a prior bypass procedure, the test is only a preliminary to balloon detachment which can then be carried out in a simple straightforward manner. It is acceptable and safe to reverse the balloon occlusion if this becomes necessary because the patient is systemically heparinized. The alternative method (that is, using a double-lumen balloon catheter ~ for the occlusion test to allow perfusion beyond the balloon with heparinized saline) appears to be unnecessary. Similarly, attempting to place a balloon distal to the aneurysm in the case of cavernous-carotid aneurysms also appears unnecessary. This maneuver adds the risk of occluding the anterior choroidal artery or introducing thrombotic material, often found within the sacs of giant aneurysms, into the intracranial circulation 2 because balloons will usually be directed into the aneurysm during manipulation. The idea that some of the very tiny branches of the cavernous carotid artery may be implicated in delayed embolic effects 1 is an interesting one. There is no good evidence, however, that proximal occlusion in our series has introduced serious risks, and this should be balanced against the definite risk of pushing clot out of an aneurysm sac by maneuvering a balloon within it.
We have not yet reinstituted attempts to treat unclippable aneurysms by intra-aneurysm balloon as is being done elsewhere. The attractive results of Romodanov and Shcheglov ~~ did include a small number of tragic complications, including aneurysm rupture by a balloon, balloon rupture leading to silicone embolization, and distal embolization by the balloon itself. A biocompatible polymerizing substance inside the balloon 14 is a protective advance in case the balloon ruptures before polymerization occurs. Intra-aneurysm balloon treatment carries more risk of potentially fatal complications than the use of the simpler balloon occlusion technique of proximal arteries for treatment of aneurysms. Unfortunately, the technique for proximal balloon occlusion described here cannot be used for balloon placement in the supraclinoid carotid artery, distal vertebral artery, or higher, because the length of the balloon necessary for such procedures would risk producing a major infarction if it occluded the anterior choroidal artery or a small perforating artery.
